Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
CAPRICOR THERAPEUTICS, INC. See All Filings	D	2017-05-18 19:16:20 UTC
Amount To Be Raised $3,708,503 Associated Brokers / Dealers N/A CIK Number 0001133869 Filed Document 0001144204-17-028496 Exclusions or Exemptions 506b Accepted Date 2017-05-18 19:16:20 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
CAPRICOR THERAPEUTICS, INC. See All Filings	D	2016-03-28 00:00:00 UTC
Amount To Be Raised $13,974 Associated Brokers / Dealers SC&H Capital CIK Number 0001133869 Filed Document 0001144204-16-090730 Exclusions or Exemptions 506b Accepted Date 2016-03-28 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
CAPRICOR THERAPEUTICS, INC. See All Filings	D	2015-02-18 00:00:00 UTC
Amount To Be Raised $7,050,001 Associated Brokers / Dealers H.C. Wainwright & Co., LLC and SC&H Capital CIK Number 0001133869 Filed Document 0001144204-15-010765 Exclusions or Exemptions 506b Accepted Date 2015-02-18 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
CAPRICOR THERAPEUTICS, INC. See All Filings	D	2015-02-03 00:00:00 UTC
Amount To Be Raised $10,002,028 Associated Brokers / Dealers SC&H Capital and H.C. Wainwright & Co., LLC CIK Number 0001133869 Filed Document 0001144204-15-005619 Exclusions or Exemptions 506b Accepted Date 2015-02-03 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
CAPRICOR THERAPEUTICS, INC. See All Filings	D	2013-12-04 00:00:00 UTC
Amount To Be Raised $26,289,973 Associated Brokers / Dealers N/A CIK Number 0001133869 Filed Document 0001144204-13-065673 Exclusions or Exemptions 506b Accepted Date 2013-12-04 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity